Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
Protara Therapeutics, Inc. has filed 783 SEC EDGAR filings since 14 Apr 2006

SEC filing history

Showing 151-175 of 778 matching filings.

Per page
25
Current page
7
S-3 File 333-279067

REGISTRATION STATEMENT

Filing date
02 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-36694

QUARTERLY REPORT

Filing date
02 May 2024
Reporting date
31 Mar 2024
Next action
Verify source filing
8-K File 001-36694

CURRENT REPORT

Filing date
02 May 2024
Reporting date
02 May 2024
Next action
Verify source filing
DEFA14A File 001-36694

DEFINITIVE ADDITIONAL MATERIALS

Filing date
26 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-36694

ANNUAL REPORT

Filing date
26 Apr 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36694

PROXY STATEMENT

Filing date
26 Apr 2024
Reporting date
07 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88372

SC 13G

Filing date
25 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88372

SC 13G

Filing date
22 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88372

SC 13G

Filing date
09 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36694

CURRENT REPORT

Filing date
05 Apr 2024
Reporting date
05 Apr 2024
Next action
Verify source filing
8-K File 001-36694

CURRENT REPORT

Filing date
18 Mar 2024
Reporting date
18 Mar 2024
Next action
Verify source filing
S-8 File 333-277931

REGISTRATION STATEMENT

Filing date
14 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-36694

ANNUAL REPORT

Filing date
13 Mar 2024
Reporting date
31 Dec 2023
Next action
Verify source filing
8-K File 001-36694

CURRENT REPORT

Filing date
13 Mar 2024
Reporting date
13 Mar 2024
Next action
Verify source filing
SC 13G/A File 005-88372

AMENDMENT NO. 2

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
23 Jan 2024
Reporting date
19 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
23 Jan 2024
Reporting date
19 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
23 Jan 2024
Reporting date
19 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
23 Jan 2024
Reporting date
19 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
23 Jan 2024
Reporting date
19 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Jan 2024
Reporting date
10 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Jan 2024
Reporting date
10 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Jan 2024
Reporting date
10 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Jan 2024
Reporting date
03 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Jan 2024
Reporting date
03 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .